Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Veronese

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Biomaterials|February 24, 2001
Peptide and protein PEGylation: a review of problems and solutionsF M Veronese
Arzneimittel-Forschung|May 1, 1987
Experimental studies in vitro and in vivo on the mutagenicity of flavoxateM Veronese, D Barzaghi
American Journal of Clinical Pathology|January 1, 1991
Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic featuresS M Veronese, M Gambacorta
Drugs of Today (Barcelona, Spain : 1998)|December 4, 2009
PEGylation for improving the effectiveness of therapeutic biomoleculesGianfranco Pasut, Francesco M Veronese
Drug Discovery Today. Technologies|July 2, 2014
PEGylation: Posttranslational bioengineering of protein biotherapeuticsFrancesco M Veronese, Gianfranco Pasut
Methods in Molecular Biology (Clifton, N.J.)|June 16, 2004
Conjugates of peptides and proteins to polyethylene glycolsMargherita Morpurgo, Francesco M Veronese
Farmaco (Societa Chimica Italiana : 1989)|October 8, 1999
Bioconjugation in pharmaceutical chemistryF M Veronese, M Morpurgo
Drug Discovery Today|October 26, 2005
PEGylation, successful approach to drug deliveryFrancesco M Veronese, Gianfranco Pasut
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 10, 2008
The impact of PEGylation on biological therapiesFrancesco M Veronese, Anna Mero
Advanced Drug Delivery Reviews|September 23, 2003
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugatesPaolo Caliceti, Francesco M Veronese
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Biomaterials|February 24, 2001
Peptide and protein PEGylation: a review of problems and solutionsF M Veronese
Arzneimittel-Forschung|May 1, 1987
Experimental studies in vitro and in vivo on the mutagenicity of flavoxateM Veronese, D Barzaghi
American Journal of Clinical Pathology|January 1, 1991
Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic featuresS M Veronese, M Gambacorta
Drugs of Today (Barcelona, Spain : 1998)|December 4, 2009
PEGylation for improving the effectiveness of therapeutic biomoleculesGianfranco Pasut, Francesco M Veronese
Drug Discovery Today. Technologies|July 2, 2014
PEGylation: Posttranslational bioengineering of protein biotherapeuticsFrancesco M Veronese, Gianfranco Pasut
Methods in Molecular Biology (Clifton, N.J.)|June 16, 2004
Conjugates of peptides and proteins to polyethylene glycolsMargherita Morpurgo, Francesco M Veronese
Farmaco (Societa Chimica Italiana : 1989)|October 8, 1999
Bioconjugation in pharmaceutical chemistryF M Veronese, M Morpurgo
Drug Discovery Today|October 26, 2005
PEGylation, successful approach to drug deliveryFrancesco M Veronese, Gianfranco Pasut
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 10, 2008
The impact of PEGylation on biological therapiesFrancesco M Veronese, Anna Mero
Advanced Drug Delivery Reviews|September 23, 2003
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugatesPaolo Caliceti, Francesco M Veronese
Pageof 16